Roswell Biotechnologies is a molecular electronics company transforming DNA sequencing with their new molecular electronics sequencing platform designed to deliver the disruptive performance required for future biomedical and industrial applications. The platform technology, ENDSeq™ (Electronic Nano-Device Sequencing), deploys single-molecule sensor nanotechnology in a scalable semiconductor chip setup to deliver a dramatic reduction in the cost of genome-sequencing with unprecedented rate, accuracy and simplicity. Roswell focuses on providing the molecular electronics chip and system that provides a $100, 1-hour whole human genome for precision medicine.